華檢醫療(01931.HK)正式啓動以太坊(ETH)金庫戰略 劍指全球最大以太坊(ETH)儲備金庫上市主體
格隆匯8月10日丨華檢醫療(01931.HK)公告宣佈,正式啓動「具備下行保護機制的全球增強版以太坊(ETH)金庫」戰略,並公佈首批定投已以每枚3661美元均價買入5190枚ETH。
該戰略以兩大核心框架爲支撐:一是建立以太幣(ETH)儲備金庫,採取定投式策略持續增持以太幣(ETH),目標成爲全球最大以太坊金庫上市主體;二是打造以太幣(ETH)創造引擎(ivd.xyz交易所),通過"創新藥IP收購—RWA代幣化—生態收益ETH化—金庫儲備增強"的閉環模式,實現資產的良性循環與增值。
這一戰略的獨特之處在於多層次"下行保護機制"。在市場波動加劇的背景下,該機制通過多元化的風險對衝手段,確保股東、RWA持有人及潛在投資者的利益安全。同時,通過多層次"增強策略"實現以太幣(ETH)資產由"被動囤幣"向"主動生息、再投資、再擴張"的質變。
這種創新性的設計,使得Web2投資者能夠在無懼市場波動的情況下,捕捉Web3鏈上金融紅利,爲傳統金融機構與數字資產之間搭建了一座穩健的橋樑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.